X4 Pharmaceuticals Inc (XFOR) — Cash Flow Quality Index
Latest as of March 2025:
-43.86x
X4 Pharmaceuticals Inc (XFOR) has a Cash Flow Quality Index of -43.86x as of March 2025. Operating cash flow of $-12.37 Million is below net income of $282.00K, suggesting accrual-heavy earnings not yet converted to cash. Also explore how large is X4 Pharmaceuticals Inc's balance sheet for the complete picture of this company's asset base.
Cash Flow Quality Index
-43.86x
Operating CF / Net Income
Operating Cash Flow
$-12.37 Million
USD
Net Income
$282.00K
USD
Data as of
Mar 2025
Most recent filing
Annual Cash Flow Quality Index for X4 Pharmaceuticals Inc (None–None)
Year-by-year earnings quality comparison for X4 Pharmaceuticals Inc. For live market cap and the full company financial profile, see X4 Pharmaceuticals Inc market capitalisation.
| Year | Quality Index | Operating CF (USD) | Net Income | YoY Change |
|---|
Cash Flow Quality Index = Operating Cash Flow / Net Income. Ratios above 1.0x indicate cash-backed earnings.